Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrapleural OK-432 or BCG via indwelling pleural catheter in mesothelioma
ISRCTN10432197Phase 3Completed
- Sponsor
- North Bristol NHS Trust
- Start
- Jan 2018
- Modality
- Vaccines & Immunotherapeutics, Therapeutic Vaccines → Vaccines & Immunotherapeutics, Cell Therapies
01
Overview
Phase 3, randomised, open-label trial of streptococcus pyogenes preparation and bcg vaccine in pleural mesothelioma (3 arms), sponsored by North Bristol NHS Trust. Primary endpoints: Recruitment feasibility, Attrition feasibility and 1 more. Started Jan 2018; status: completed.
02
Drugs
streptococcus pyogenes preparationbcg vaccine
03
Conditions
pleural mesothelioma
Beyond the preview
Go deeper on ISRCTN10432197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10432197.